Cutera Past Earnings Performance

Past criteria checks 0/6

Cutera's earnings have been declining at an average annual rate of -49.7%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 4.6% per year.

Key information

-49.7%

Earnings growth rate

-44.4%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate4.6%
Return on equityn/a
Net Margin-92.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Cutera, Inc. (NASDAQ:CUTR) Looks Inexpensive After Falling 47% But Perhaps Not Attractive Enough

Aug 20
Cutera, Inc. (NASDAQ:CUTR) Looks Inexpensive After Falling 47% But Perhaps Not Attractive Enough

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 28% Dive

Jun 22
Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 28% Dive

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive

Mar 14
Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive

Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be

Aug 11
Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be

An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued

Apr 19
An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued

Does Cutera (NASDAQ:CUTR) Have A Healthy Balance Sheet?

Jan 11
Does Cutera (NASDAQ:CUTR) Have A Healthy Balance Sheet?

Would Cutera (NASDAQ:CUTR) Be Better Off With Less Debt?

Oct 06
Would Cutera (NASDAQ:CUTR) Be Better Off With Less Debt?

Cutera: Shares Very Attractively Priced, Top-Line Hedged From CMS

Sep 08

Cutera, Inc. (NASDAQ:CUTR) Shares Could Be 49% Below Their Intrinsic Value Estimate

Sep 01
Cutera, Inc. (NASDAQ:CUTR) Shares Could Be 49% Below Their Intrinsic Value Estimate

Cutera: The 'AviClear' Sign To Get Bullish

Jun 22

Cutera (NASDAQ:CUTR) Is Carrying A Fair Bit Of Debt

May 27
Cutera (NASDAQ:CUTR) Is Carrying A Fair Bit Of Debt

Revenue & Expenses Breakdown

How Cutera makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:CUTR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24155-14413218
30 Jun 24169-14913219
31 Mar 24197-15815920
31 Dec 23212-16316421
30 Sep 23230-11316622
30 Jun 23247-8116924
31 Mar 23249-9515625
31 Dec 22252-8215325
30 Sep 22251-7814727
30 Jun 22245-6813726
31 Mar 22240-1312624
31 Dec 21231211022
30 Sep 2121689819
30 Jun 2119779116
31 Mar 21165-128315
31 Dec 20148-248414
30 Sep 20150-288715
30 Jun 20157-299315
31 Mar 20178-179615
31 Dec 19182-129515
30 Sep 19175-379014
30 Jun 19170-358414
31 Mar 19165-378315
31 Dec 18163-317914
30 Sep 18165187814
30 Jun 18162257515
31 Mar 18156297113
31 Dec 17151306613
30 Sep 17142116112
30 Jun 1713475812
31 Mar 1712545711
31 Dec 1611835511
30 Sep 1611005311
30 Jun 16103-25111
31 Mar 1698-34911
31 Dec 1595-44811
30 Sep 1590-84811
30 Jun 1586-104710
31 Mar 1581-114510
31 Dec 1478-114311
30 Sep 1475-94210
30 Jun 1473-84010
31 Mar 1475-63910
31 Dec 1375-5389

Quality Earnings: CUTR is currently unprofitable.

Growing Profit Margin: CUTR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CUTR is unprofitable, and losses have increased over the past 5 years at a rate of 49.7% per year.

Accelerating Growth: Unable to compare CUTR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CUTR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).


Return on Equity

High ROE: CUTR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies